Commission publishes joint clinical assessment reports on two new lung cancer medicines
08 July 2026 by Wendy WINN (DG SANTE, European Commission)The Commission has published two joint clinical assessment (JCA) reports: on tarlatamab (Imdylltra) and on lurbinectedin (Zepzelca). Both are orphan medicinal products for the treatment of extensive-stage small cell lung cancer. The assessments were carried out by competent authorities of Germany...